Literature DB >> 8378254

Physiological parameters in laboratory animals and humans.

B Davies1, T Morris.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8378254     DOI： 10.1023/a:1018943613122

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  611 in total

1.  Pharmacokinetics of gentamicin C(1), C(1a), and C(2) in beagles after a single intravenous dose.

Authors:  N Isoherranen; E Lavy; S Soback
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Kinetic modeling of plasmid DNA degradation in rat plasma.

Authors:  B E Houk; G Hochhaus; J A Hughes
Journal:  AAPS PharmSci       Date:  1999

3.  Relationship of pharmacokinetically-calculated volumes of distribution to the physiologic distribution of liposomal drugs in tissues: implications for the characterization of liposomal formulations.

Authors:  R M Fielding
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

4.  Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration.

Authors:  Jian Li; Robert W Milne; Roger L Nation; John D Turnidge; Timothy C Smeaton; Kingsley Coulthard
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

Review 5.  The Clinical Pharmacology of Elotuzumab.

Authors:  Chaitali Passey; Jennifer Sheng; Johanna Mora; Amol Tendolkar; Michael Robbins; Robert Dodge; Amit Roy; Akintunde Bello; Manish Gupta
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

Review 6.  Pharmacokinetic and pharmacodynamic perspectives on the clinical drug development of panitumumab.

Authors:  Bing-Bing Yang; Peggy Lum; Alin Chen; Rosalin Arends; Lorin Roskos; Brian Smith; Juan José Pérez Ruixo
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

7.  Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human.

Authors:  Dhaval K Shah; Alison M Betts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-12-06       Impact factor: 2.745

8.  A Translational Physiologically Based Pharmacokinetics/Pharmacodynamics Framework of Target-Mediated Disposition, Target Inhibition and Drug-Drug Interactions of Bortezomib.

Authors:  Shinji Iwasaki; Andy Zhu; Michael Hanley; Karthik Venkatakrishnan; Cindy Xia
Journal:  AAPS J       Date:  2020-04-14       Impact factor: 4.009

9.  Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.

Authors:  S M D K Ganga Senarathna; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

10.  Pharmacokinetics, mass balance, and tissue distribution of a novel DNA alkylating agent, VNP40101M, in rat.

Authors:  John Mao; Yang Xu; Diana Wu; Bijan Almassain
Journal:  AAPS PharmSci       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.